Cargando…

Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients

Metabolic brain biomarkers have been incorporated in various diagnostic guidelines of neurodegenerative diseases, recently. To improve their diagnostic accuracy a biologically and clinically homogeneous sample is needed for their identification. Alzheimer’s disease-related pattern (ADRP) has been id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perovnik, Matej, Tomše, Petra, Jamšek, Jan, Emeršič, Andreja, Tang, Chris, Eidelberg, David, Trošt, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273623/ https://www.ncbi.nlm.nih.gov/pubmed/35817836 http://dx.doi.org/10.1038/s41598-022-15667-9

Ejemplares similares

Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography
por: Perovnik, Matej, et al.
Publicado: (2022)

Automated differential diagnosis of dementia syndromes using FDG PET and machine learning
por: Perovnik, Matej, et al.
Publicado: (2022)

Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern
por: Štokelj, Eva, et al.
Publicado: (2023)

Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia
por: Rus, Tomaž, et al.
Publicado: (2022)

Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer’s Disease and Dementia
por: Vogrinc, David, et al.
Publicado: (2023)

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
por: Trošt, Maja, et al.
Publicado: (2019)

Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia
por: Beach, Thomas G., et al.
Publicado: (2020)

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
por: Crum, Jana, et al.
Publicado: (2018)

Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
por: Karikari, Thomas K., et al.
Publicado: (2020)

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
por: Perrin, Richard J., et al.
Publicado: (2011)

Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer’s disease: An autopsy-confirmed study
por: Morimoto, Satoru, et al.
Publicado: (2017)

Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
por: Leyhe, Thomas, et al.
Publicado: (2013)

Identifying and validating biomarkers for Alzheimer's disease
por: Humpel, Christian
Publicado: (2011)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
por: Maclin, Joshua Marvin Anthony, et al.
Publicado: (2019)

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
por: Thomas, Alan J., et al.
Publicado: (2018)

Examination of a non-invasive biomarker for the diagnosis of prodromal Alzheimer's disease and Alzheimer's disease Dementia
por: Dupree, Emmalyn J., et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2022)

Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease
por: Pan, Dan, et al.
Publicado: (2022)

Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation
por: Yao, Fang, et al.
Publicado: (2019)

Dementia / Alzheimer's Disease
por: Lindsay, Joan, et al.
Publicado: (2004)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease
por: Öhrfelt, Annika, et al.
Publicado: (2011)

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
por: Bousiges, Olivier, et al.
Publicado: (2022)

Serum 24‐hydroxycholesterol in probable Alzheimer's dementia: Reexploring the significance of a tentative Alzheimer's disease biomarker
por: Roy, Debashree, et al.
Publicado: (2019)

Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
por: Chatterjee, Atri, et al.
Publicado: (2021)

Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
por: DiBello, Julia R., et al.
Publicado: (2023)

Metabolic Brain Changes Can Predict the Underlying Pathology in Neurodegenerative Brain Disorders: A Case Report of Sporadic Creutzfeldt–Jakob Disease with Concomitant Parkinson’s Disease
por: Rus, Tomaž, et al.
Publicado: (2023)

Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
por: Wang, Huimin, et al.
Publicado: (2021)

Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort
por: Planche, Vincent, et al.
Publicado: (2023)

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort
por: Liljegren, Madeleine, et al.
Publicado: (2019)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
por: Alexopoulos, Panagiotis, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
por: Disbrow, Elizabeth, et al.
Publicado: (2021)

Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
por: Giacomucci, Giulia, et al.
Publicado: (2021)

REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia
por: Luo, Jiefeng, et al.
Publicado: (2022)

Frontotemporal dementia to Alzheimer's disease
por: Silveri, Maria Caterina
Publicado: (2007)

Nutrition and prevention of Alzheimer’s dementia
por: Swaminathan, Arun, et al.
Publicado: (2014)

Caregiving in Alzheimer’s and Other Dementias
por: Horien, Corey
Publicado: (2016)

Non-Alzheimer's and atypical dementia
por: Chandra, S. R.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qclkd7kb5ta4j0utbsbq8p5a4t